2024 Stroke Council Award Lecture - Hooman Kamel, MD, FAHA

 

Dr. Hooman Kamel is the Helen and Albert Moon professor and vice chair for research in the department of neurology at Weill Cornell Medicine. He is also chief of the division of neurocritical care and director of the clinical and translational neuroscience unit in the department of neurology and the Feil Family Brain and Mind Research Institute.

His research focuses on the relationship between cardiac disease and stroke. He has published several studies showing that atrial cardiopathy may be a previously unrecognized risk factor for stroke. He was a principal investigator and protocol lead for the NIH-funded ARCADIA trial, which tested antithrombotic strategies in patients with stroke and atrial cardiopathy. He is also a principal investigator of the NIH-funded ASPIRE trial, which is testing antithrombotic strategies in patients with atrial fibrillation and intracerebral hemorrhage. He has published over 400 scientific publications, including in leading journals such as NEJM and JAMA.

Dr. Kamel is co-chair of the NIH StrokeNet Prevention Working Group, co-chair of the Multi-Ethnic Study of Atherosclerosis Brain Working Group, and a steering committee member of the international AF-SCREEN collaboration. He served on the writing committee for the American Heart Association’s most recent prevention guidelines for secondary stroke. He serves on the leadership committees of several multicenter randomized trials, including STROKE-AF, Librexia AF, REACT-AF and LAAOS-4.

Dr. Kamel attended college at Harvard University and medical school at Columbia University, then trained as a neurology resident and neurocritical care fellow at the University of California, San Francisco. He has a master’s degree in data science from the Columbia University Data Science Institute. He is deputy editor of JAMA Neurology and an editorial board member of Stroke.

His academic contributions have been recognized with the Michael S. Pessin Stroke Leadership Prize from the American Academy of Neurology, and the Robert G. Siekert New Investigator Award in Stroke and the Joseph A. Vita Award from the AHA.